Live tape
Top 8, mentions 7d10,859GOOGL2,228 mentions▲ +0.03HTZ1,725 mentions▲ +0.10SPCX1,467 mentions▲ +0.08NBIS1,417 mentions▲ +0.10SNDK1,297 mentions▲ +0.11NVDA1,151 mentions▲ +0.08MSFT842 mentions▲ +0.06SPY732 mentions▲ +0.06

Equity · Healthcare

VTRS

Viatris Inc. · NasdaqGS

$17.30 −0.06% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 41 sessions
$18 $15 19 May 17 Jul

The line runs $16.17 on 19 May through $17.30 on 17 July, on a scale from $15 to $18. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of VTRS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 41 sessions over that window: $16.17 on 19 May 2026 through $17.30 on 17 July 2026.

Market cap $19.9B
52-week range $8.75 – $17.38
Avg volume 3.0M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 17, 2026

VTRS insider trades

SEC Form 4 · last 90 days · newest reported trade 25 Jun 2026
Open-market buys 0
Open-market sells 1
Net sold $810K
Non-trade filings 0
Date Insider Type Shares Value
25 Jun 2026 Campbell Paul See Remarks Sell 50,076 $810K

VTRS reported financials

SEC EDGAR XBRL

VTRS reported revenue of $14.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$3.5B.

Figure Reported Period
Revenue $14.3B 31 Dec 2025 fiscal year
Net income −$3.5B 31 Dec 2025 fiscal year
Diluted EPS −$3.00 31 Dec 2025 fiscal year
Total assets $35.0B 30 Jun 2026 at period end
Total equity incl. minority interest $14.3B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

VTRS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.10 $3.76B
31 Mar 2026 Q1 2026 $0.15 $3.52B
31 Dec 2025 FY 2025 $-3.00 $14.30B
30 Sep 2025 Q3 2025 $-0.11 $3.76B
30 Jun 2025 Q2 2025 $0.00 $3.58B
31 Mar 2025 Q1 2025 $-2.55 $3.25B
31 Dec 2024 FY 2024 $-0.53 $14.74B
30 Sep 2024 Q3 2024 $0.08 $3.75B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

VTRS institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a VTRS position for the quarter ended 30 Jun 2026 — a combined $369.2M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Glenview Capital Management Held (±25%) +8.7% shares 9,877,409 $156.9M
AQR Capital Management Trimmed −26.0% shares 4,694,966 $74.6M
Man Group Held (±25%) −13.9% shares 3,523,052 $55.9M
Bridgewater Associates Added +134.0% shares 1,698,341 $27.0M
Marshall Wace Trimmed −91.0% shares 839,820 $13.3M
D. E. Shaw & Co. Trimmed −79.6% shares 791,371 $12.6M
Point72 Asset Management Trimmed −68.3% shares 563,129 $8.9M
Citadel Advisors Trimmed −87.4% shares 502,259 $8.0M
Millennium Management Trimmed −88.6% shares 314,043 $5.0M
Two Sigma Investments Held (±25%) +18.6% shares 238,000 $3.8M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

VTRS fails-to-deliver

SEC CNS data

On 09 Jul 2026, 338 shares of VTRS failed to deliver (about $6K).

Settlement date Shares failed Notional % of shares out
09 Jul 2026 338 $6K <0.001%
07 Jul 2026 480 $8K <0.001%
06 Jul 2026 468 $8K <0.001%

Source: SEC fails-to-deliver (CNS) data